Literature DB >> 8893275

Transdermal delivery of fentanyl by electroporation. II. Mechanisms involved in drug transport.

R Vanbever1, N D Morre, V Préat.   

Abstract

PURPOSE: The aim of the present report was to systematically analyze the mechanisms involved in fentanyl transdermal transport by skin electroporation.
METHODS: The study was performed in vitro with full-thickness hairless rat skin, skin electroporation being carried out with five exponentially-decaying pulses of 100 V applied voltage and around 600 ms pulse duration.
RESULTS: Transport during and after pulsing are both important in transdermal delivery of fentanyl by skin electroporation. Rapid transport occurred during pulsing due to electrophoresis and diffusion through highly permeabilized skin. No electroosmosis was observed. The slow post-pulse passive transport was explained by lasting changes in skin permeability. Measurements of fentanyl quantities in the skin demonstrated that pulses rapidly loaded the viable part of the skin with fentanyl and hence rapidly overcame skin barrier.
CONCLUSIONS: The different contributions of the transport mechanisms appear to depend on the physicochemical parameters of the transported molecule as well as the solution, suggesting that mechanistic analysis and careful consideration of formulation variables are essential for the development and optimization of drug delivery by skin electroporation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8893275     DOI: 10.1023/a:1016073917125

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Factors affecting iontophoretic mobility of metoprolol.

Authors:  S Thysman; V Préat; M Roland
Journal:  J Pharm Sci       Date:  1992-07       Impact factor: 3.534

2.  Transdermal permeation of neutral molecules by skin electroporation.

Authors:  R Vanbever; M A Leroy; V Préat
Journal:  J Control Release       Date:  1998-08-14       Impact factor: 9.776

3.  Transdermal delivery of fentanyl by electroporation. I. Influence of electrical factors.

Authors:  R Vanbever; E LeBoulengé; V Préat
Journal:  Pharm Res       Date:  1996-04       Impact factor: 4.200

4.  Transdermal transport of DNA antisense oligonucleotides by electroporation.

Authors:  T E Zewert; U F Pliquett; R Langer; J C Weaver
Journal:  Biochem Biophys Res Commun       Date:  1995-07-17       Impact factor: 3.575

5.  Transdermal delivery of metoprolol by electroporation.

Authors:  R Vanbever; N Lecouturier; V Préat
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

6.  Absorption characteristics of transdermally administered fentanyl.

Authors:  J R Varvel; S L Shafer; S S Hwang; P A Coen; D R Stanski
Journal:  Anesthesiology       Date:  1989-06       Impact factor: 7.892

7.  Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro.

Authors:  D B Bommannan; J Tamada; L Leung; R O Potts
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

8.  Transdermal delivery of heparin by skin electroporation.

Authors:  M R Prausnitz; E R Edelman; J A Gimm; R Langer; J C Weaver
Journal:  Biotechnology (N Y)       Date:  1995-11

9.  Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil.

Authors:  S D Roy; G L Flynn
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

10.  Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery.

Authors:  M R Prausnitz; V G Bose; R Langer; J C Weaver
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

  10 in total
  1 in total

Review 1.  Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.

Authors:  S Grond; L Radbruch; K A Lehmann
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.